Stereotaxis is a global leader in developing robotic technologies that improve the treatment of arrhythmias and coronary diseases. The company's core technologies include the Niobe® ES Remote Magnetic Navigation system, the Odyssey™ portfolio of lab optimization and patient information management systems, and the Vdrive™ Robotic Mechanical Navigation system and consumables. Stereotaxis' mission is to discover, develop, and deliver robotic systems, instruments, and information solutions for the interventional laboratory. The company generates revenue from Systems, Disposables, Royalty, and Sublease streams, with Disposables, service, and accessories being the primary source. The majority of the company's revenue is generated in the United States.